戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ctivity in the presence of H(2) (70 bar) and diethylenetriamine.
2  pyrolysis of citric acid in the presence of diethylenetriamine.
3 G), and d-mannaro-1,4:6,3-dilactone (M) with diethylenetriamine (1), triethylenetetramine (2), tetrae
4 ess, we studied the effects of the NO donors diethylenetriamine and spermine NONOate and the peroxyni
5 oteins, the complexes [Pt(dien)Cl]Cl (dien = diethylenetriamine) and [Pt(terpy)Cl]Cl (terpy = 2,2':6'
6              We introduce two new versatile (diethylenetriamine) building blocks for solid-phase synt
7 ical substrate N-1[3(trimethoxysilyl)propyl] diethylenetriamine (DETA) and fabricated microcantilever
8 y (diethylethanolamine, DEAE), and triamine (diethylenetriamine, DETA), respectively.
9 -ammonioethyl)amino]diazen-1-ium-1,2-diolate diethylenetriamine elicited NO and ROI production, Ca(2+
10 0-tetraacetic acid monoamide (DOTA-MA), or a diethylenetriamine ligand (DETA-propanoic acid [PA]), fo
11                               Diastereomeric diethylenetriamine N-glycoside zinc(II) complexes are in
12 ive of the Eu3+-chelate of N-(p-benzoic acid)diethylenetriamine-N,N',N"-tetraacetic acid (DTTA), inco
13  Eu3+ chelate of N1-(p-isothiocyanatobenzyl)-diethylenetriamine-N1,N2,N3,N3-tetraacetic acid and then
14 atment of hCSCs with a widely used NO donor, diethylenetriamine nitric oxide adduct (DETA-NO), promot
15 N-acetylcysteine, the nitric oxide generator diethylenetriamine nitric oxide, 8-bromo-cGMP, and 8-(4-
16 nts, S-nitroso-N-acetylpenicillamine (SNAP), diethylenetriamine NO adduct (DETA-NO), and sodium nitro
17  after a chronic treatment with an NO donor: diethylenetriamine-NO (DETA-NO).
18 pared with two other NO-releasing compounds, diethylenetriamine-NO and the organic nitrate, isosorbid
19 fication to a similar extent as the NO donor diethylenetriamine-NO, and their osteoinductive effects
20 ced pharmacologically by giving the NO donor diethylenetriamine/NO (DETA/NO) (at a dose previously sh
21 ation of 2 structurally unrelated NO donors, diethylenetriamine/NO (DETA/NO) and S-nitroso-N-acetylpe
22        When rabbits were given the NO donors diethylenetriamine/NO (DETA/NO, 0.1 mg/kg i.v., 4 times
23                                 The NO donor diethylenetriamine/NO recapitulated the effects of ische
24  S-nitroso-N-penicillamine (SNAP, 25 muM) or diethylenetriamine-NONO (DETA-NO, 50 muM), exhibited ele
25 e tracheal epithelial) cells with 100 microm diethylenetriamine NONOate (DETA NONOate) for 24-96 h de
26 re exposed to S-nitrosoglutathione (GSNO) or diethylenetriamine NONOate (DETA NONOate).
27 nistration of NMDA and a nitric oxide donor, diethylenetriamine NONOate) peroxynitrite.
28 mmonioethyl) amino]diazen-1-ium-1,2-diolate (diethylenetriamine NONOate, DETA-NO) (1 mmol/liter) unde
29                              Terpyridine and diethylenetriamine penta-acetic acid (5-500 microM) caus
30 njugated to isothiocyanato-2-benzyl-3-methyl-diethylenetriamine-penta-a cetic acid and labeled with e
31 sequence, and the metal ion chelator N(3)-Bn-diethylenetriamine pentaacetate (DTPA) to allow radiolab
32 ed and evaluated Eu(3+) complexes of several diethylenetriamine pentaacetate (DTPA)-monoamide ligands
33  low concentrations of hydrochloric acid and diethylenetriamine pentaacetate (DTPA).
34 converted into the corresponding aminobenzyl-diethylenetriamine pentaacetate conjugates 23 and 26.
35 stered (111)In-labeled alphavbeta6-specific (diethylenetriamine pentaacetate-tetra [DTPA]-A20FMDV2) o
36 ) after injection of 0.15 mmol/kg gadolinium diethylenetriamine-pentaacetate using an adjusted TI.
37 sively by the renal tubules, whereas (99m)Tc-diethylenetriamine pentaacetic acid ((99m)Tc-DTPA) is pr
38 1In-labeled 1,4-methyl-benzyl isothiocyanate diethylenetriamine pentaacetic acid (111In-MX-DTPA) BrE-
39 d to the 2-(4-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid (1B4M-DTPA, also kno
40                    The iron (III) complex of diethylenetriamine pentaacetic acid (DTPA iron [III]) pr
41 etic surfactant (Exosurf) on pulmonary 99mTc-diethylenetriamine pentaacetic acid (DTPA) aerosol depos
42     Two groups of subjects were studied with diethylenetriamine pentaacetic acid (DTPA) baseline and
43 h ethylenediaminetetraacetic acid (EDTA) and diethylenetriamine pentaacetic acid (DTPA) were found to
44 erformed with a glomerular filtration agent, diethylenetriamine pentaacetic acid (DTPA), and a tubula
45                           Indium-111-labeled diethylenetriamine pentaacetic acid (DTPA)-folate was ev
46 ods used for the preparation of (213Bi)CHX-A-diethylenetriamine pentaacetic acid (DTPA)-HuM195, an al
47 ised to a Pb(II)-loaded isothiocyanatobenzyl-diethylenetriamine pentaacetic acid (DTPA)-protein conju
48  detect retinal vascular leakage, gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) enhanced M
49  seen in MRI 5 to 7 minutes after gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) injection,
50 after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA).
51 globulin G had a higher T/B ratio than 111In-diethylenetriamine pentaacetic acid (p < 0.01) or 111In-
52 d significant acceleration of technetium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) cleara
53 otracer of choice compared to technetium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) for im
54 cted mutagenesis and metal chelators such as diethylenetriamine pentaacetic acid and deferoxamine, we
55 tized with the bifunctional chelator CHX-A''-diethylenetriamine pentaacetic acid and then bound to th
56 ined with MRPI after injection of gadolinium-diethylenetriamine pentaacetic acid at rest and during h
57 electron donating capacities, revealing that diethylenetriamine pentaacetic acid is an effective cand
58  of phenol red or independently by [(99m)Tc]-diethylenetriamine pentaacetic acid scintigraphy, was re
59 2*-weighted three-dimensional and gadolinium-diethylenetriamine pentaacetic acid T1-weighted MRI.
60 odecane-1,4,7,10-tetraacetic acid) and DTPA (diethylenetriamine pentaacetic acid) are commonly used t
61     Simultaneous renal scans (technetium-99m diethylenetriamine pentaacetic acid) of the native and t
62 phic contrast agent (gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid).
63 were conjugated with biotin and 111In-benzyl diethylenetriamine pentaacetic acid, and, at various tim
64 ation was detectable in levels of gadolinium-diethylenetriamine pentaacetic acid- or VCAM-MPIO-positi
65 Other less traditional probes include 99m Tc diethylenetriamine pentaacetic acid-galactosyl-human ser
66 omeruler filtration rate measured with 99mTc-diethylenetriamine pentaacetic acid.
67  SPECT following injection of technetium 99m diethylenetriamine pentaacetic acid.
68 m, enabled by the universal complexing agent diethylenetriamine pentaacetic acid.
69     The 125I-iothalamate clearance and 99mTc diethylenetriamine-pentaacetic acid (99mTc-DTPA) split s
70 uals underwent (125)I-iothalamate or (99m)Tc-diethylenetriamine-pentaacetic acid (DTPA) renal studies
71 iary (HB) phase with gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) with d
72 fter the intravenous injection of gadolinium diethylenetriamine-pentaacetic acid.
73 m iodide, sodium diatrizoate, and gadolinium diethylenetriamine-pentaacid (Gd-DTPA).
74 sing an alternative ventilation agent, 99mTc-diethylenetriamine pentacetic acid (DTPA) aerosol, and s
75    In contrast to the conventional MRI agent diethylenetriamine-pentatacetate gadolinium, which repor
76 NNN)H(2) = N-methyl-N',N"-bis(trimethylsilyl)diethylenetriamine; R = alkyl, aryl), is capable of cata
77                               Interestingly, diethylenetriamine tetraacetic acid did not form fluores
78                                Indium-benzyl-diethylenetriamine tetraacetic acid was identified as a
79 fter delivery to hepatocytes, (111)In-benzyl-diethylenetriamine tetraacetic acid, was then used for r
80 H2valdien = N1,N3-bis(3-methoxysalicylidene) diethylenetriamine, the terminal ligand L = NO3(-) (1),
81 ine (TMSPEDA), N-[3-(trimethoxysilyl)propyl]-diethylenetriamine (TMSPETA), and tetraethoxyorthosilane
82 te (TMOS) and N'[3-(trimethoxysilyl)-propyl]-diethylenetriamine (TPDA) were used in a 1:1 mole ratio
83 ne (AE-APTES) and N-(3-trimethoxysilylpropyl)diethylenetriamine (TPDA), are used to generate the amin
84 rine, (ii) the low-temperature alkylation of diethylenetriamines with the triflate of benzyl glycolat